Last reviewed · How we verify
Neonatal hypocalcemia
Approved treatments
- Alfarol
Alfarol works by activating vitamin D receptors in the body, which helps regulate calcium levels. - Alphacalcidol · University of Ioannina
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neonatal hypocalcemia patent landscape — cliff calendar, originator estates, attackable patents
- Neonatal hypocalcemia treatment landscape brief
- Neonatal hypocalcemia treatment updates RSS
Frequently asked questions about Neonatal hypocalcemia
What drugs treat Neonatal hypocalcemia?
Tracked treatments include Alfarol, Alphacalcidol.
What is the treatment for Neonatal hypocalcemia?
Standard treatment for Neonatal hypocalcemia includes Alfarol, Alphacalcidol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neonatal hypocalcemia patent cliff · Neonatal hypocalcemia CI report
- Treatment: Alfarol
- Treatment: Alphacalcidol · University of Ioannina
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing